Literature DB >> 18306241

Autoimmune myelopathy associated with collapsin response-mediator protein-5 immunoglobulin G.

B Mark Keegan1, Sean J Pittock, Vanda A Lennon.   

Abstract

Several autoimmune myelopathies are recognized clinically. We describe 57 patients in whom serological evaluation for myelopathy of uncertain cause demonstrated collapsin response-mediator protein 5 IgG. Most had spinal imaging and cerebrospinal fluid abnormalities and insidiously progressive presentation; some had acute monophasic or relapsing myelopathy. Initial diagnoses included multiple sclerosis, transverse myelitis, and unspecified neurodegenerative myelopathy. Most were smokers; neoplasia was discovered in 68% (most commonly small-cell lung carcinoma and after collapsin response-mediator protein-5 IgG detection). Collapsin response-mediator protein-5 autoimmune myelopathy and occult neoplasia are important considerations in patients with insidiously progressive myelopathy, especially with known cancer risk.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18306241     DOI: 10.1002/ana.21324

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  14 in total

1.  Neural autoantibody evaluation in functional gastrointestinal disorders: a population-based case-control study.

Authors:  Sean J Pittock; Vanda A Lennon; Carissa L Dege; Nicholas J Talley; G Richard Locke
Journal:  Dig Dis Sci       Date:  2010-12-23       Impact factor: 3.199

Review 2.  Neuromyelitis optica spectrum disorders.

Authors:  Eoin P Flanagan; Brian G Weinshenker
Journal:  Curr Neurol Neurosci Rep       Date:  2014-09       Impact factor: 5.081

3.  Neuromyelitis optica - an update: 2007-2009.

Authors:  Anu Jacob
Journal:  Ann Indian Acad Neurol       Date:  2009-10       Impact factor: 1.383

4.  Secondary intramedullary spinal cord non-Hodgkin's lymphoma.

Authors:  Eoin P Flanagan; Brian Patrick O'Neill; Thomas M Habermann; Alyx B Porter; B Mark Keegan
Journal:  J Neurooncol       Date:  2011-12-22       Impact factor: 4.130

5.  Ganglionic Antibody Level as a Predictor of Severity of Autonomic Failure.

Authors:  Jeremy K Cutsforth-Gregory; Andrew McKeon; Elizabeth A Coon; David M Sletten; Mariana Suarez; Paola Sandroni; Wolfgang Singer; Eduardo E Benarroch; Robert D Fealey; Phillip A Low
Journal:  Mayo Clin Proc       Date:  2018-08-28       Impact factor: 7.616

6.  Acute necrotizing encephalopathy (ANE1): rare autosomal-dominant disorder presenting as acute transverse myelitis.

Authors:  Katharina Wolf; Thomas Schmitt-Mechelke; Spyridon Kollias; Armin Curt
Journal:  J Neurol       Date:  2013-01-18       Impact factor: 4.849

7.  Paraneoplastic and other autoimmune disorders of the central nervous system.

Authors:  Andrew McKeon
Journal:  Neurohospitalist       Date:  2013-04

8.  Investigation of the KIR4.1 potassium channel as a putative antigen in patients with multiple sclerosis: a comparative study.

Authors:  Adipong Brickshawana; Shannon R Hinson; Michael F Romero; Claudia F Lucchinetti; Yong Guo; Mathias Buttmann; Andrew McKeon; Sean J Pittock; Min-Hwang Chang; An-Ping Chen; Thomas J Kryzer; James P Fryer; Sarah M Jenkins; Philippe Cabre; Vanda A Lennon
Journal:  Lancet Neurol       Date:  2014-07-06       Impact factor: 44.182

9.  Ganglionic acetylcholine receptor autoantibody: oncological, neurological, and serological accompaniments.

Authors:  Andrew McKeon; Vanda A Lennon; Daniel H Lachance; Robert D Fealey; Sean J Pittock
Journal:  Arch Neurol       Date:  2009-06

10.  Paraneoplastic neuromyelitis optica spectrum disorder associated with metastatic carcinoid expressing aquaporin-4.

Authors:  Michelle Figueroa; Yong Guo; Alexandros Tselis; Sean J Pittock; Vanda A Lennon; Claudia F Lucchinetti; Robert P Lisak
Journal:  JAMA Neurol       Date:  2014-04       Impact factor: 18.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.